Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Rankning i aktier #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Aktiekurs
$0.11725176
Senast synkroniserad: 2025-07-14
Marknadsvärde
$481.50K
Förändring (1 dag)
-0.20%
Förändring (1 år)
0.00%
Land
FR
Handel PHAXIAM Therapeutics S.A. (PHXM)

Kategori

Historik för aktiesplit för PHAXIAM Therapeutics S.A. (PHXM)
Aktien PHAXIAM Therapeutics S.A. (symbol: PHXM) har genomgått totalt 2 aktiesplitar.
Den senaste spliten skedde den Jun 13, 2024.
En PHXM-aktie köpt före Sep 18, 2023 motsvarar nu 0.10819672131148 PHXM-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2024-06-13 66:61 x1.0819672131148 x0.10819672131148
2023-09-18 1:10 x0.1 x0.1
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE